Relationships between selenium, lipids, iron status and hormonal therapy in women of the SU.VI.M.AX cohort

Journal of Trace Elements in Medicine and Biology

Volumn 21, Issue SUPPL. 1, 2007, Pages 66-69

  Arnaud, Josiane ^a,b,d   Arnault, Nathalie ^b   Roussel, Anne Marie ^b,c,d   Bertrais, Sandrine ^b   Ruffieux, Daniel ^a   Galan, Pilar ^b   Favier, Alain ^a,c,d   Hercberg, Serge ^b,d  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIV GRENOBLE ALPES   (France)

^d SFERETE (Societe Francophone d'Etude et de Recherche sur les Elements Toxiques et Essentiels) member   (France)

Author keywords

Hormonal status; Iron status; Lipid profile; Serum selenium; Women

Indexed keywords

APOLIPOPROTEIN A1; FERRITIN; IRON; LIPID; ORAL CONTRACEPTIVE AGENT; SELENIUM;

ADULT; AGED; ARTICLE; BLEEDING; COHORT ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; INTRAUTERINE CONTRACEPTIVE DEVICE; LIPID BLOOD LEVEL; MENOPAUSE; PRIORITY JOURNAL;

EID: 36348952153     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2007.09.025     Document Type: Article

References (20)

1. Arnaud J., Bertrais S., Roussel A.M., Arnault N., Ruffieux D., Favier A., Berthelin S., Estaquio C., Galan P., Czernichow S., and Hercberg S. Serum selenium determinants in French adults: the SU. VI.M.AX study. Br J Nutr 95 (2006) 313-320
2. Verlinden M., Van Sprundel M., Van der Auwera J.C., and Eylenbosch W.J. The selenium status of Belgian population groups. 1. Healthy adults. Biol Trace Elem Res 5 (1983) 91-102
3. Bureau I., Anderson R.A., Arnaud J., Raysiguier Y., Favier A.E., and Roussel A.M. Trace mineral status in post menopausal women: impact of hormonal replacement therapy. J Trace Elem Med Biol 16 (2002) 9-13
4. Smith A.M., Chang M.P., and Medeiros L.C. Generational differences in selenium status of women. Biol Trace Elem Res 75 (2000) 157-165
5. Holdcroft C. Combined oral contraceptive pills: a brief review. Nurse Pract 19 (1994) 5, 11-2, 15
6. Hercberg S., Galan P., Preziosi P., Bertrais S., Mennen L., Malvy D., Roussel A.M., Favier A., and Briancon S. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164 (2004) 2335-2342
7. Hercberg S., Preziosi P., Briancon S., Galan P., Triol I., Malvy D., Roussel A.M., and Favier A. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin Trials 19 (1998) 336-351
8. Arnaud J., Prual A., Preziosi P., Favier A., and Hercberg S. Selenium determination in human milk in Niger: influence of maternal status. J Trace Elem Electrolytes Health Dis 7 (1993) 199-204
9. Bruckert E., Czernichow S., Bertrais S., Paillard F., Tichet J., Galan P., Castetbon K., and Hercberg S. Blood lipid and lipoprotein levels: relationships with educational level and region of residence in the French SU.VI.MAX study. Prev Med 40 (2005) 803-811
10. Hercberg S., Bertrais S., Czernichow S., Noisette N., Galan P., Jaouen A., Tichet J., Briancon S., Favier A., Mennen L., and Roussel A.M. Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX study. Lipids 40 (2005) 335-342
11. Hercberg S., Estaquio C., Czernichow S., Mennen L., Noisette N., Bertrais S., Renversez J.C., Briancon S., Favier A., and Galan P. Iron status and risk of cancers in the SU.VI.MAX cohort. J Nutr 135 (2005) 2664-2668
12. Luoma P.V., Sotaniemi E.A., Korpela H., and Kumpulainen J. Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol effect of selenium supplementation. Res Commun Chem Pathol Pharmacol 46 (1984) 469-472
13. Navarro-Alarcon M., de la Serrana H.L., Perez-Valero V., and Lopez-Martinez C. Serum selenium levels as indicators of body status in cancer patients and their relationship with other nutritional and biochemical markers. Sci Total Environ 212 (1998) 195-202
14. Salonen J.T., Salonen R., Seppanen K., Kantola M., Parviainen M., Alfthan G., Maenpaa P.H., Taskinen E., and Rauramaa R. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 70 (1988) 155-160
15. Viegas-Crespo A.M., Pavao M.L., Paulo O., Santos V., Santos M.C., and Neve J. Trace element status (Se, Cu, Zn) and serum lipid profile in Portuguese subjects of San Miguel Island from Azores'archipelago. J Trace Elem Med Biol 14 (2000) 1-5
16. Gurgoze M.K., Aygun A.D., Olcucu A., Dogan Y., and Yilmaz E. Plasma selenium status in children with iron deficiency anemia. J Trace Elem Med Biol 18 (2004) 193-196
17. McAnulty L.S., Gropper S.S., McAnulty S.R., and Keith R.E. Iron depletion without anemia is not associated with impaired selenium status in college-aged women. Biol Trace Elem Res 91 (2003) 125-136
18. Semba R.D., Ferrucci L., Cappola A.R., Ricks M.O., Ray A.L., Xue Q.L., Guralnik J.M., and Fried L.P. Low serum selenium is associated with anemia among older women living in the community: the Women's Health and Aging Studies I and II. Biol Trace Elem Res 112 (2006) 97-107
19. Moriarty P.M., Picciano M.F., Beard J.L., and Reddy C.C. Classical selenium-dependent glutathione peroxidase expression is decreased secondary to iron deficiency in rats. J Nutr 125 (1995) 293-301
20. Balla J., Vercellotti G.M., Jeney V., Yachie A., Varga Z., Eaton J.W., and Balla G. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 49 (2005) 1030-1043